The Phase 2 FORGE-LM study tests oral NAMPT activator SIR4156 on fat and body composition. Sironax says mouse work showed preserved lean mass, but human data are still pending.
Recap by typeshit. Full story at Longevity.Technology.
The Scientist weighs whether GLP-1 drugs could lengthen life and finds the answer still unsettled. Tap through for where the research stands.
The review covers 47 peptides from meat, leather and seafood waste and cites a 12-trial meta-analysis showing a systolic drop of about 5 mmHg, credited to the authors.
Researchers think orexin drugs could expand into ADHD and fatigue the way GLP-1s grew past diabetes. Alkermes reported early ADHD results in 50 adults.
Researchers report in Amino Acids that the peptide blocks HMGA2 at the IL6 promoter in a cell model. The authors note the work is cell culture only, far from any human use.
Among Medicare patients with type 2 diabetes, GLP-1 use jumped more than sixteenfold from 2010 to 2022. L'Oréal is also making skincare for rapid weight loss effects.
MedPage Today
MedPage's roundup also notes GLP-1 use among Medicare patients with type 2 diabetes rose more than 16-fold from 2010 to 2022, and L'Oréal building skincare for rapid weight loss.
Loading…